Thank you all for being here today. This is an important study. To those of you I know as witnesses, and your teams in the gallery, it's nice to see you again. To those I don't know, it's still nice to see you, just in a different context.
It does feel like we are looking at a bit of a global nuclear renaissance. I think that comes at the right time as Canada looks at its electricity plans going out to 2050 and beyond. Of course, nuclear is 15% of our nation's generation right now. It's an important part of our mix. If we wanted even just to sustain that mix, it would mean significant build-outs.
I really want to focus my questions in this round on nuclear as a global industry, including medical isotopes. I want to, in particular, canvass all three of our witnesses for their view of global opportunities as well as global challenges and do a bit of a tour of the table for what we need to think about in terms of Canada as a player in a global industry and building on the success that we've seen in this space.
Maybe we can start with you, Mr. Boutziouvis.
